Holen Sie sich die Stockscreener-App
6.08
5.88%
-0.38
Handel nachbörslich:
6.04
-0.04
-0.66%
Schlusskurs vom Vortag:
$6.46
Offen:
$6.3
24-Stunden-Volumen:
23,919
Relative Volume:
0.02
Marktkapitalisierung:
$5.47M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.77M
KGV:
-0.00462
EPS:
-1316.2474
Netto-Cashflow:
$-14.37M
1W Leistung:
-16.71%
1M Leistung:
-17.84%
6M Leistung:
+3,504%
1J Leistung:
-73.79%
1-Tages-Spanne:
$6.08
$6.45
1-Wochen-Bereich:
$6.08
$6.904
52-Wochen-Spanne:
$0.0927
$48.80
Glucotrack Inc Stock (GCTK) Company Profile
Firmenname
Glucotrack Inc
Sektor
Telefon
972 (8) 675-7878
Adresse
301 RT 17 NORTH, RUTHERFORD
Vergleichen Sie GCTK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
6.08 | 5.88M | 0 | -26.77M | -14.37M | -1,316.25 |
|
ISRG
Intuitive Surgical Inc
|
538.82 | 192.92B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
179.04 | 50.82B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
74.19 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
246.40 | 36.34B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
286.94 | 20.13B | 2.96B | 487.70M | 344.00M | 6.6758 |
Glucotrack Inc Aktie (GCTK) Neueste Nachrichten
How GlucoTrack Inc. stock reacts to bond yieldsDip Buying & Intraday High Probability Setup Alerts - newser.com
GlucoTrack Inc. stock daily chart insightsForecast Cut & Fast Entry High Yield Tips - newser.com
Does GlucoTrack Inc. stock trade at a discount to peersStock Surge & Free Safe Entry Trade Signal Reports - newser.com
Published on: 2025-11-04 00:24:46 - newser.com
How interest rate cuts could boost GlucoTrack Inc. stockMarket Growth Report & Community Consensus Picks - newser.com
How GlucoTrack Inc. stock reacts to job market dataPortfolio Risk Report & Stepwise Entry and Exit Trade Signals - newser.com
GlucoTrack Announces Special Shareholders Meeting for Equity Deal - TipRanks
Glucotrack, Inc. Encourages Shareholders to Vote on Equity Purchase Agreement - TradingView
Glucotrack, Inc. Encourages Shareholders to Vote - The Manila Times
Glucotrack (NASDAQ: GCTK) sets Nov 7 meeting to vote on more than 20% share issuance - Stock Titan
Key resistance and support levels for GlucoTrack Inc.July 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Technical analysis overview for GlucoTrack Inc. stock2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Can machine learning forecast GlucoTrack Inc. recoveryJuly 2025 Trends & Target Return Focused Stock Picks - newser.com
GlucoTrack Inc trading resumes - MSN
GCTK registers 20,060,000 shares for Sixth Borough resale - Stock Titan
What drives GlucoTrack Inc stock priceIPO Market Watch & Build Wealth With Zero-Cost Tools - earlytimes.in
GlucoTrack Inc trading halted, volatility trading pause - MSN
Glucotrack’s Innovative Glucose Sensor Study: A Potential Game-Changer for Diabetes Management - MSN
GlucoTrack Appoints Dr. Usman Latif to Advisory Team - TipRanks
Glucotrack, Inc. Appoints Usman Latif to Clinical Advisory Team - TradingView
[8-K] Glucotrack, Inc. Reports Material Event | GCTK SEC FilingForm 8-K - Stock Titan
Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team - The Manila Times
Glucotrack (NASDAQ: GCTK) taps Dr. Usman Latif to guide epidural glucose monitoring - Stock Titan
GlucoTrack Announces Special Shareholder Meeting for Equity Vote - TipRanks
Glucotrack, Inc. Announces Special Shareholder Meeting - TradingView
GCTK files 8-K; Regulation FD press release furnished (Ex. 99.1) - Stock Titan
Glucotrack, Inc. Reminds Shareholders to Vote - The Manila Times
How to read the order book for GlucoTrack Inc.July 2025 Levels & Risk Controlled Daily Plans - newser.com
Glucotrack (NASDAQ: GCTK) sets Oct 31 special meeting on Equity Purchase Agreement - Stock Titan
Finanzdaten der Glucotrack Inc-Aktie (GCTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.48%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):